Nordisk Stock Drops After CagriSema Misses Weight Loss Goal in Key Trial
Shares of Danish pharmaceutical company Novo Nordisk A/S fell sharply on Monday following the release of results from its latest obesity drug trial. The
by
February 23, 2026
Welcome to Surf Radio Falmouth — your trusted online platform for reliable news, timely updates, and meaningful stories from the United Kingdom and around the world.
Disclaimer
All content on Surf Radio Falmouth is published for general informational purposes only.
While we strive for accuracy, we make no guarantees regarding completeness, reliability, or timeliness.
Nav Link
Follow Us
Copyright ©2026
Surf Radio Falmouth. All Rights Reserved.